Quick Links

 Ultra High Throughput Sequencing with Solexa

We offer ultra high throughput DNA sequencing services on the Illumina Genome Analyzer II (formerly known as the Solexa) platform. Using a massively parallel sequencing approach, the Illumina GAII can generate up to 2 billion bases of data in a single lane or up to 16 billion bases of data in a single run. The system uses Solexa sequencing technology and novel reversible terminator chemistry, optimized to achieve unprecedented levels of cost effectiveness and throughput. More information describing this technology and its application is available at the Illumina Web site.

Applications

The following technologies have been developed for this platform:

  • DNA-seq: de novo sequencing or re-sequencing
  • ChIP-seq: DNA-protein interactions across the entire genome
  • Methyl-seq: methylation profiling
  • RNA-seq: mRNA expression, splicing, mutations/cSNP
  • smRNA-seq: small RNA/miRNA discovery, profiling
  • Structure variant detection: deletions, duplications, insertion, inversion and rearrangements
  • Multiplexed Sample Sequencing with barcodes

Sample Submission Form
Please fill out the Sample Submission Form and bring it when you drop off your sample.

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.